Self-binding antibodies (autobodies) form specific complexes in solution
- PMID: 2212652
Self-binding antibodies (autobodies) form specific complexes in solution
Abstract
In this report we have shown that members of the murine self-binding antibody family, S107, form soluble complexes and precipitate under conditions in which non-self-binding antibodies remain in solution. Two approaches were used to demonstrate the self-association of autobodies: size-exclusion column chromatography and polyethylene glycol (PEG)-mediated precipitation assay. The anti-phosphorylcholine antibody T15 and two somatic variants, U4, which binds DNA, and U10, which has no identified specificity, produced larger precipitates in 10% PEG than other non-self-binding antibodies. The selectivity of PEG-mediated precipitation of self-binding antibodies is demonstrated by reduction of precipitation with specific haptens known to inhibit self-binding in solid-phase assays. Phosphorylcholine and nucleotides reduced precipitation of T15 and U4, respectively, but not U10. To rule out Fc-Fc mediated self-association in solution, we have also demonstrated self-complexing of F(ab')2 fragments of T15 using PEG. The self-binding locus was further dissected using peptides derived from V regions. A 24-residue peptide derived from the second hypervariable region of the VH of S107 specifically enhanced precipitation of T15, U4, and U10, but not other antibodies. These results provide evidence of a dormant potential of self-binding antibodies to precipitate under conditions that reduce the solubility of proteins. The implication of this potential is discussed with respect to pathological complex formation.
Similar articles
-
Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus.J Immunol. 1990 Dec 15;145(12):4207-13. J Immunol. 1990. PMID: 2124238
-
Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.J Immunol. 1984 Mar;132(3):1544-9. J Immunol. 1984. PMID: 6420465
-
Properties of anti-idiotypic T cell lines propagated with syngeneic B lymphocytes. I. T cells bind intact idiotypes and discriminate between the somatic idiotypic variants in a manner similar to the anti-idiotopic antibodies.J Immunol. 1988 Dec 1;141(11):3718-25. J Immunol. 1988. PMID: 3263431
-
Pharmacokinetics and biodistribution of genetically-engineered antibodies.Q J Nucl Med. 1998 Dec;42(4):225-41. Q J Nucl Med. 1998. PMID: 9973838 Review.
-
Homophilic antibodies as immunotherapeutics.Immunotherapy. 2013 Mar;5(3):235-46. doi: 10.2217/imt.12.159. Immunotherapy. 2013. PMID: 23444953 Review.
Cited by
-
Physical and biological properties of homophilic therapeutic antibodies.Cancer Immunol Immunother. 2011 Apr;60(4):507-14. doi: 10.1007/s00262-010-0952-8. Epub 2010 Dec 28. Cancer Immunol Immunother. 2011. PMID: 21188585 Free PMC article.
-
Generation of a potent recombinant homophilic chimeric anti-CD20 antibody.Hybridoma (Larchmt). 2012 Dec;31(6):395-402. doi: 10.1089/hyb.2012.0073. Hybridoma (Larchmt). 2012. PMID: 23244317 Free PMC article.
-
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody.Cancer Immunol Immunother. 2007 Feb;56(2):147-54. doi: 10.1007/s00262-006-0182-2. Epub 2006 Aug 3. Cancer Immunol Immunother. 2007. PMID: 16896968 Free PMC article.
-
The Homophilic Domain - An Immunological Archetype.Front Immunol. 2016 Mar 21;7:106. doi: 10.3389/fimmu.2016.00106. eCollection 2016. Front Immunol. 2016. PMID: 27047493 Free PMC article. Review.
-
Paradoxical concentration effect of a homodimerizing antibody against a human non-small cell lung cancer cell line.Cancer Immunol Immunother. 2009 May;58(5):749-58. doi: 10.1007/s00262-008-0597-z. Epub 2008 Sep 27. Cancer Immunol Immunother. 2009. PMID: 18820910 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources